Tech Company Financing Transactions
General Biotechnologies Funding Round
General Biotechnologies, based in San Francisco, raised $7.4 million from Kompas and Ritual Capital.
Transaction Overview
Company Name
Announced On
7/20/2026
Transaction Type
Venture Equity
Amount
$7,400,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA Undisclosed
USA
San Francisco, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
General Biotechnologies manufactures peptide therapeutics at a fraction of the current cost by genetically programming edible microbes to synthesise complex molecules.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Kim
Browse more venture capital transactions:
Prev: 7/20/2026: Veriqus Financial Services venture capital transaction
Next: 7/20/2026: BeCertain venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs